Melanocortin signaling

PT-141 / Bremelanotide

Human research exists for a regulated formulation

UNDERSTAND IT SIMPLY

What is PT-141 / Bremelanotide?

PT-141 is another name for bremelanotide, a molecule that activates melanocortin receptors. This research looks at signaling in the brain and nervous system. Scientists study how those signals relate to neuroendocrine communication and certain aspects of sexual response.

Human research exists for a specific regulated formulation. That evidence applies to the formulation and controlled conditions used in those studies; it does not prove separately supplied material is identical, pure or safe. This is not a treatment recommendation and provides no dosing, preparation or use instructions.

WHAT RESEARCHERS EXAMINE

Melanocortin-receptor activity

Neuroendocrine signaling

Controlled sexual-response endpoints

HUMAN EVIDENCE

What human research has reported.

Applies only to the tested regulated formulation and defined population.

In trials of regulated bremelanotide, some participants reported improved desire scores and less related distress.

These are group-level study observations—not promises, instructions or personal predictions. Benefits, side effects, study design and uncertainty must be considered together.

GO TO THE SOURCE

Read beyond the summary.

ClinicalTrials.gov studies↗PubMed research↗

INFORMATION—NOT A PRODUCT PAGE.

PJ Peptides does not offer this compound for sale. This page does not provide medical advice, diagnosis, treatment, dosing, preparation, administration or sourcing guidance.